Hyloris Pharmaceuticals【0AB6】銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

買値

0.00

売値

0.00

出来高

1,580

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

前日終値

0.00

始値

時刻

6.78

(O)

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

発行済株式数

28,000,000

配当利回り

PER

-12.74

1 株当たり利益 (EPS)

-0.55

歳入

4.21M

純利益

-15.38M

セクター

Pharmaceutical Preparations

業界

Pharmaceutical Preparations

ウェブサイト

www.hyloris.com

本社

Liege, Liege, Bel

設立

Hyloris Pharmaceuticals Sa is listed in the Pharmaceutical Preparations sector of the ロンドン証券取引所 with ticker 0AB6. The last closing price for Hyloris Pharmaceuticals was 0.00 €. Over the last year, Hyloris Pharmaceuticals shares have traded in a share price range of 0.00 € to 0.00 €.

Hyloris Pharmaceuticals currently has 28,000,000 shares in issue. Hyloris Pharmaceuticals has a price to earnings ratio (PE ratio) of -12.74.

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives

Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives Le total des produits et autres revenus atteint 4,4...

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook

Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Hyloris Reports Full Year Results for 2023 & Provides Business Outlook Total revenue and other income amounted to...

Communication at the request of the FSMA on the transactions with Qliniq

Communication at the request of the FSMA on the transactions with Qliniq Communication at the request of the FSMA on the transactions with Qliniq Revision of 2022 and half-year of 2023 (HY 2023...

Communiqué à la requête de la FSMA sur les transactions avec QliniQ

Communiqué à la requête de la FSMA sur les transactions avec QliniQ Communiqué à la requête de la FSMA sur les transactions avec QliniQ Retraitement des états financiers de 2022 et de juin 2023...

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024

Hyloris Annonce ses Résultats Financiers Annuels le 14 mars 2024 Liège, Belgique – le 8 mars 2024, 07:00 heures CET - Information non réglementée - Hyloris Pharmaceuticals SA (Euronext Bruxelles :...

Hyloris to Report 2023 Full-Year Results on 14 March 2024

Hyloris to Report 2023 Full-Year Results on 14 March 2024 Liège, Belgium – 08 February 2024, 07:00 AM CET – Non-regulated information – Hyloris Pharmaceuticals SA (Euronext Brussels: HYL), a...

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada

Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada Hyloris Annonce le Lancement de Maxigesic® IV aux Etats-Unis ainsi que son Approbation au Canada...

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada

Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Hyloris Announces Launch of Maxigesic® IV in the U.S. and approval In Canada Maxigesic® IV, a Potent Non-opioid...

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures

Hyloris Enrolls First Patient in Phase 3 Clinical Trial for its Proprietary Mouth Rinse to Control Incidences of Bleeding Related to Dental Procedures Innovative oral care solution aims to benefit...

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires

Hyloris Recrute un Premier Patient dans le Cadre d'un Essai Clinique de Phase 3 portant sur son Rince-Bouche Breveté Destiné à Contrôler les Saignements lors des Interventions Dentaires Une...

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	0	0	0	0	0	DE
52	0	0	0	0	0	0	0	DE
156	0	0	0	0	0	0	0	DE
260	0	0	0	0	0	0	0	DE

0AB6 - Frequently Asked Questions (FAQ)

What is the current Hyloris Pharmaceuticals share price?

The current share price of Hyloris Pharmaceuticals is 0.00 €

How many Hyloris Pharmaceuticals shares are in issue?

Hyloris Pharmaceuticals has 28,000,000 shares in issue

What is the 1 year trading range for Hyloris Pharmaceuticals share price?

Hyloris Pharmaceuticals has traded in the range of 0.00 € to 0.00 € during the past year

What is the PE ratio of Hyloris Pharmaceuticals?

The price to earnings ratio of Hyloris Pharmaceuticals is -12.74

What is the cash to sales ratio of Hyloris Pharmaceuticals?

The cash to sales ratio of Hyloris Pharmaceuticals is 46.51

What is the reporting currency for Hyloris Pharmaceuticals?

Hyloris Pharmaceuticals reports financial results in EUR

What is the latest annual turnover for Hyloris Pharmaceuticals?

The latest annual turnover of Hyloris Pharmaceuticals is EUR 4.21M

What is the latest annual profit for Hyloris Pharmaceuticals?

The latest annual profit of Hyloris Pharmaceuticals is EUR -15.38M

What is the registered address of Hyloris Pharmaceuticals?

The registered address for Hyloris Pharmaceuticals is BOULEVARD PATIENCE ET BEAUJONC, LIEGE, LIEGE, 4000

What is the Hyloris Pharmaceuticals website address?

The website address for Hyloris Pharmaceuticals is www.hyloris.com

Which industry sector does Hyloris Pharmaceuticals operate in?

Hyloris Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

出来高
値上がり率
値下がり率

銘柄コード	株価	出来高
CLAICel Ai Plc	0.085p (41.67%)	20.65M
ZEDZenova Group Plc	0.675p (22.73%)	4.33M
GFINGfinity Plc	0.07p (21.74%)	118M
SDXSdx Energy Plc	0.424p (21.14%)	28.44M
OBDOxford Biodynamics Plc	1.45p (20.83%)	1.79M
QUIZQuiz Plc	0.745p (-15.82%)	5.25M
SRESSunrise Resources Plc	0.0275p (-15.38%)	43.75M
PPSProton Motor Power Systems Plc	0.275p (-15.38%)	401.8k
ALTEAlteration Earth Plc	10.75p (-14.00%)	1.87M
SYMESupply@me Capital Plc	0.0034p (-13.92%)	513.5M
TRPTower Resources Plc	0.037p (8.82%)	991.59M
SYMESupply@me Capital Plc	0.0034p (-13.92%)	513.5M
NTVONativo Resources Plc	0.002p (0.00%)	399.34M
PREMPremier African Minerals Limited	0.044p (-12.87%)	296.47M
NTOGNostra Terra Oil And Gas Company Plc	0.027p (3.85%)	273.27M